Sara Fernández-Castillejo1, Laura Rubió1,2, Álvaro Hernáez3, Úrsula Catalán1, Anna Pedret1,4, Rosa-M Valls1, Juana I Mosele2, Maria-Isabel Covas3,5, Alan T Remaley6,7, Olga Castañer3, Maria-José Motilva2, Rosa Solá1. 1. Research Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Functional Nutrition, Oxidation, and Cardiovascular Disease (NFOC-SALUT) group, Universitat Rovira i Virgili, Reus, Spain. 2. Food Technology Department, Agrotecnio Center, University of Lleida, Lleida, Spain. 3. Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Barcelona, Spain. 4. Eurecat-Centre Tecnològic de Nutrició i Salut (Eurecat-CTNS), Reus, Spain. 5. NUPROAS Handelsbolag, Nackă, Sweden. 6. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA. 7. Lipoprotein Metabolism Section, Cardio-Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract
SCOPE: Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to assess which HDL parameters were CEC determinants after virgin olive oil (VOO) ingestion. METHODS AND RESULTS: Post-hoc analyses from the VOHF study, a crossover intervention with three types of VOO. We assessed the relationship of 3-week changes in HDL-related variables after intervention periods with independence of the type of VOO. After univariate analyses, mixed linear models were fitted with variables related with CEC and fluidity. Fluidity and Apolipoprotein (Apo)A-I content in HDL was directly associated, and HDL oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL mean size, were associated to HDL fluidity. CONCLUSIONS:HDL fluidity, ApoA-I concentration, and oxidative status are major determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL functionality in humans through nutritional or pharmacological interventions.
RCT Entities:
SCOPE: Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to assess which HDL parameters were CEC determinants after virginoliveoil (VOO) ingestion. METHODS AND RESULTS: Post-hoc analyses from the VOHF study, a crossover intervention with three types of VOO. We assessed the relationship of 3-week changes in HDL-related variables after intervention periods with independence of the type of VOO. After univariate analyses, mixed linear models were fitted with variables related with CEC and fluidity. Fluidity and Apolipoprotein (Apo)A-I content in HDL was directly associated, and HDL oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL mean size, were associated to HDL fluidity. CONCLUSIONS: HDL fluidity, ApoA-I concentration, and oxidative status are major determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL functionality in humans through nutritional or pharmacological interventions.
Authors: Dick C Chan; Anh Hoang; P Hugh R Barrett; Annett T Y Wong; Paul J Nestel; Dmitri Sviridov; Gerald F Watts Journal: J Clin Endocrinol Metab Date: 2012-06-28 Impact factor: 5.958
Authors: Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul Journal: N Engl J Med Date: 2014-11-18 Impact factor: 91.245
Authors: María-Isabel Covas; Kristiina Nyyssönen; Henrik E Poulsen; Jari Kaikkonen; Hans-Joachim F Zunft; Holger Kiesewetter; Antonio Gaddi; Rafael de la Torre; Jaakko Mursu; Hans Bäumler; Simona Nascetti; Jukka T Salonen; Montserrat Fitó; Jyrki Virtanen; Jaume Marrugat Journal: Ann Intern Med Date: 2006-09-05 Impact factor: 25.391
Authors: Karla Paulina Luna-Castillo; Sophia Lin; José Francisco Muñoz-Valle; Barbara Vizmanos; Andres López-Quintero; Fabiola Márquez-Sandoval Journal: Nutrients Date: 2021-04-01 Impact factor: 5.717
Authors: Sara Fernández-Castillejo; Anna Pedret; Úrsula Catalán; Rosa-Maria Valls; Marta Farràs; Laura Rubió; Olga Castañer; Alba Macià; Montse Fitó; Maria José Motilva; Maria-Isabel Covas; Martin Giera; Alan T Remaley; Rosa Solà Journal: Mol Nutr Food Res Date: 2021-03-18 Impact factor: 6.575
Authors: Elena Grao-Cruces; Lourdes M Varela; Maria E Martin; Beatriz Bermudez; Sergio Montserrat-de la Paz Journal: Nutrients Date: 2021-03-16 Impact factor: 5.717